...
首页> 外文期刊>American journal of rhinology & allergy >Endoscopically guided chitosan nasal packing for intractable epistaxis
【24h】

Endoscopically guided chitosan nasal packing for intractable epistaxis

机译:内镜引导的壳聚糖鼻填充治疗顽固性鼻出血

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The purpose of this study was to evaluate the effectiveness and safety of endoscopically guided chitosan packing in controlling intractable epistaxis. A prospective case series was performed.Methods: This is a prospective clinical study conducted in a tertiary rhinology fellowship training hospital between January 2009 and November 2009. The study population consisted of patients with intractable epistaxis that failed to respond to traditional anterior-posterior nasal packing using either a 10-cm Pope PVA Merocel or a Rapid-Rhino. The bleeding site was identified using a nasal endoscope and controlled using a pack made of a ChitoFlex chitosan dressing wrapped around a polyvinyl acetal nasal sponge.Results: The intent-to-treat population consisted of 20 severe epistaxis subjects (8 men and 12 women) who continued to bleed despite traditional anterior-posterior nasal packing. The mean age was 67 years (? years). Sixteen subjects were on antiplatelets and/or anticoagulants. Eleven subjects (55%) presented with anterior epistaxis, and 7 subjects (35%) presented with posterior epistaxis. Chitosan nasal packing was performed on an outpatient basis and resulted in effective and immediate hemostasis in 19/20 subjects (95%). One subject had persistent bleeding after the first packing attempt and was successfully repacked within 30 minutes. Time to complete cessation of bleeding was 3.6 ? 2.2 minutes in the 19 subjects; the pack was removed after 48 hours, without any evidence of rebleeding or any serious side effects.Conclusion: Endoscopically guided chitosan packing is a safe, effective, and well-tolerated outpatient treatment for the management of intractable epistaxis.
机译:背景:本研究的目的是评估内镜引导的壳聚糖包装在控制顽固性鼻出血中的有效性和安全性。方法:这是一项前瞻性临床研究,于2009年1月至2009年11月期间在一家三级流变学研究培训医院进行。研究人群包括顽固的鼻st患者,他们对传统的前鼻后包装没有反应使用10厘米Pope PVA Merocel或Rapid-Rhino。使用鼻内窥镜确定出血部位,并使用包裹在聚乙烯醇缩醛鼻海绵上的ChitoFlex壳聚糖敷料制成的包装进行控制。结果:意向性治疗人群由20名严重的鼻epi患者组成(8名男性和12名女性)尽管传统的前-后鼻填充法,但仍持续出血。平均年龄为67岁(?年)。 16名受试者接受了抗血小板和/或抗凝剂治疗。 11名受试者(55%)出现前鼻epi,7名受试者(35%)出现后鼻st。壳聚糖鼻包装是在门诊进行的,导致19/20名受试者(95%)的有效和立即止血。第一次包装后,一名受试者持续出血,并在30分钟内成功重新包装。完成止血的时间为3.6? 19个科目2.2分钟;结论:内镜引导的壳聚糖包装是安全,有效且耐受良好的门诊治疗顽固性鼻出血的治疗方法,在48小时后取出包装,无任何再出血或严重副作用的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号